Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder

Modern Pathology

Volumn 20, Issue 5, 2007, Pages 592-603

  Sukov, William R ^a   Cheville, John C ^a   Carlson, Austin W ^a   Shearer, Brandon M ^a   Piatigorsky, Eli J ^a   Grogg, Karen L ^a   Sebo, Thomas J ^a   Sinnwell, Jason P ^a   Ketterling, Rhett P ^a  

^a MAYO CLINIC   (United States)

Author keywords

ALK; Fluorescence in situ hybridization; Inflammatory myofibroblastic tumor; Spindle cell lesion; Urinary bladder

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANAPLASTIC LYMPHOMA KINASE 1; ANTIGEN; CYTOKERATIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BLADDER TUMOR; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; EPITHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR DENDRITIC CELL; GENE EXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; MALE; MUSCLE CELL; NERVE CELL; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; SPINDLE CELL CARCINOMA;

ACTIVIN RECEPTORS, TYPE II; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MYOFIBROMA; REPRODUCIBILITY OF RESULTS; SARCOMA; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 34247325226     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800776     Document Type: Article

References (37)

1. Arber DA, Kamel OW, van de Rijn M, et al. Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol 1995;26:1093-1098.
2. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002;15:931-938.
3. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour In: Fletcher CDM, Unni KK, Mertens F (eds). World Health Organization Classification of Tumours: Tumours of Soft Tissue and Bone. IARC Press: Lyons, France, 2002;91-93.
4. Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001;14:569-576.
5. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000;157:377-1384.
6. Mergan F, Jaubert F, Sauvat F, et al. Inflammatory myofibroblastic tumor in children: clinical review with anaplastic lymphoma kinase, Epstein-Barr virus, and human herpesvirus 8 detection analysis. J Pediatr Surg 2005;40:1581-1586.
7. Montgomery EA, Shuster DD, Burkart AL, et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example of inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol 2006;30:1502-1512.
8. Neuhauser TS, Derringer GA, Thompson LD, et al. Splenic inflammatory myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunophenotypic study of 12 cases. Arch Pathol Lab Med 2001;125:379-385.
9. O'Malley DP, Poulos C, Czader M, et al. Intraocular inflammatory myofibroblastic tumor with ALK overexpression. Arch Pathol Lab Med 2004;128:e5-e7.
10. Harik LR, Merino C, Coindre JM, et al. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 2006;30:787-794.
11. Iczkowski KA, Shanks JH, Gadaleanu V, et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirtyeight spindle cell neoplasms. Mod Pathol 2001;14:1043-1051.
12. Lundgren L, Aldenborg F, Angervall L, et al. Pseudomalignant spindle cell proliferation of the urinary bladder. Hum Pathol 1994;25:181-191.
13. Tsuzuki T, Magi-Galluzzi C, Epstein JI. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am J Surg Pathol 2004;28:1609-1614.
14. Hirsch MS, Dal Cin P, Fletcher CD. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract. Histopathology 2006;48:569-578.
15. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364-1371.
16. Weidner N. Inflammatory (myofibroblastic) pseudotumor of the bladder: a review and differential diagnosis. Adv Anat Pathol 1995;1995:362-375.
17. Young RH, Wick MR, Mills SE. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic analysis of 12 cases and review of the literature. Am J Clin Pathol 1988;90:651-653.
18. Chan JK, Cheuk W, Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am J Surg Pathol 2001;25:761-768.
19. Freeman A, Geddes N, Munson P, et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Mod Pathol 2004;17:765-771.
20. Griffin CA, Hawkins AL, Dvorak C, et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999;59:2776-2780.
21. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003;37:98-105.
22. Panagopoulos I, Nilsson T, Domanski HA, et al. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 2006;118:1181-1186.
23. Sirvent N, Hawkins AL, Moeglin D, et al. ALK probe rearrangement in a t(2;11;2)(p23;p15;q31) translocation found in a prenatal myofibroblastic fibrous lesion: toward a molecular definition of an inflammatory myofibroblastic tumor family? Genes Chromosomes Cancer 2002;31:85-90.
24. Yousem SA, Shaw H, Cieply K. Involvement of 2p23 in pulmonary inflammatory pseudotumors. Hum Pathol 2001;32:428-433.
25. Debiec-Rychter M, Marynen P, Hagemeijer A, et al. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003;38:187-190.
26. Cheuk W, Chan JK, Shek TW, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol 2001;25:721-731.
27. Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol 2005;18:260-266.
28. Pillay K, Govender D, Chetty R. ALK protein expression in rhabdomyosarcomas. Histopathology 2002;41:461-467.
29. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001;159:411-415.
30. Cools J, Wlodarska I, Somers R, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002;34:354-362.
31. Debelenko LV, Arthur DC, Pack SD, et al. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest 2003;83:1255-1265.
32. Kazmierczak B, Cin PD, Sciot R, et al. Inflammatory myofibroblastic tumor with HMGIC rearrangement. Cancer Genet Cytogenet 1998;112:156-160.
33. Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. Blood 1998;92:2688-2695.
34. Yamamoto H, Oda Y, Saito T, et al. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours. Histopathology 2003;42:431-439.
35. Nonaka D, Birbe R, Rosai J. So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells? Histopathology 2005;46:604-613.
36. Lopez-Beltran A, Sauter G, Gasser T, et al. Infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, et al (eds). World Health Organization Classification of Tumours: Tumours of the Urinary System and Male Genital Organs. IARC Press: Lyons, France, 2004, pp 93-109.
37. Cheville JC, Dundore PA, Nascimento AG, et al. Leiomyosarcoma of the prostate. Report of 23 cases. Cancer 1995;76:1422-1427.